Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus

Diabetic Medicine

Volumn 15, Issue 2, 1998, Pages 113-119

  Humphrey, A R G ^a   McCarty, D J ^b   Mackay, I R ^c   Rowley, M J ^c   Dwyer, T ^d   Zimmet, P ^b,c  

^a Redbridge Waltham Forest Hlth Auth   (United Kingdom)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d The Menzies Foundation   (Australia)

Author keywords

Diabetes mellitus; Disease classification; Epidemiology; Glutamic acid decarboxylase; IDDM; NIDDM

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN;

ADULT; AGED; ARTICLE; AUSTRALIA; BODY MASS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; ENZYME ACTIVITY; FAMILY HISTORY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PHENOTYPE; SEX DIFFERENCE;

ADULT; AGE OF ONSET; AGED; AUTOANTIBODIES; COHORT STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PHENOTYPE; REGRESSION ANALYSIS; SEX CHARACTERISTICS; TASMANIA; TIME FACTORS;

EID: 0031907502     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199802)15:2<113::AID-DIA528>3.0.CO;2-D     Document Type: Article

References (32)

1. Molbak A, Christau B, Marner B, Borch-Johnsen K, Nerup J. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabetic Med 1994; 11: 650-655.
2. Maislos M, Weitzman S. Prevalence of IDDM in adults in the community. Diabetes Care 1995; 18: 885-886.
3. Melton L, Palumbo P, Chu C. Incidence of diabetes mellitus by clinical type. Diabetes Care 1983; 6: 75-86.
4. Tuomi T, Groop L, Zimmet P, Rowley M, Knowles W, Mackay I. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent onset of disease. Diabetes 1993; 42: 359-362.
5. Welborn T, Garcia-Webb P, Bonser A. Basal C-peptide in the discrimination of type I from type II diabetes. Diabetes Care 1981; 4: 616-619.
6. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva: WHO, 1985.
7. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
8. Willis JA, Scott RS, Brown LJ, Forbes LV, Schmidli RS, Zimmet PZ, et al. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 89-97.
9. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 1997; 350: 1288-93.
10. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before the clinical onset of the disease. Lancet 1994; 343: 1383-1385.
11. King H, Senator G, Zimmet P, Harris A. The Tasmanian insulin-treated diabetes register. Inception and process in the first twelve months. Med J Aust 1986; 144: 414-416.
12. Chen Q-Y, Rowley MJ, Bryne GC, Jones TW, Tuomi T, Knowles WJ, et al. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Pediatric Res 1993; 34: 785-790.
13. Schmidli R, Colman P, Bonefacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADab workshop. Diabetes 1995; 44: 636-640.
14. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1987.
15. Breslow N, Day N. Statistical Methods in Cancer Research, vol. I: The Analysis of Case-Control Studies. Lyon: IARC, 1980.
16. SPSS Inc. SPSSX User's Guide. New York: McGraw Hill, 1986.
17. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epiclemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 883-892.
18. Scott R, Brown L. Prevalence and incidence of insulintreated diabetes mellitus in adults in Canterbury, New Zealand. Diabetic Med 1991; 8: 1-8.
19. Palmer J, Asplin C, Clemons R, Lyen K, Tatpati O, Reghu RK, et al. Insulin antibodies in insulin dependent diabetes before insulin treatment. Science 1983; 222: 1337-1339.
20. Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Betrams J, et al. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 1984; 27: 90-92.
21. Groop L, Bottazzo G, Doniach D. Islet cell antibodies identity latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986; 35: 237-241.
22. Vandewalle C, Falorni A, Svanholm S, Lernmark A, Pipeleers D, Gorus F. High diagnostic sensitivity of glutamic decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between 20 and 40 years. J Clin Endocrinol Metab 1995; 80: 846-851.
23. Gottsater A, Landin-Olsson M, Lernmark A, Ferlund P, Sundkvist G, Hagopian W. Glutamate decarboxylase antibody levels predict the rates of beta-cell decline in adult-onset diabetes. Diabetes Res Clin Pract 1995; 27: 133-140.
24. Zimmet P. Antibodies to glutamic acid decarboxylase in the prediction of insulin dependency. Diabetes Res Clin Pract 1996; 34: (suppl): s125-s131.
25. Imagawa A, Itoh N, Hanafusa T, Katgura H, Yamaguchi A, Takeda A, et al. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus. Res Commun Mol Pathol Pharmacol 1996; 9: 379-383.
26. Prior M, Prout T, Miller D, Ewart R, Kumar D. C-peptide and the classification of diabetes melliltus in the early treatment of diabetic retinopathy study. Ann Epidemiol 1993; 3: 9-17.
27. Vadheim C, Rotter J. Genetics of diabetes mellitus. In: Alberti K, DeFronzo R, Keen H, Zimmet P, eds. International Textbook of Diabetes Mellitus. Chichester: Wiley. 1992: 31-39.
28. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
29. Graber A, Davidson P, Brown A, McRae J, Wooldridge K. Dropout and relapse during diabetes care. Diabetes Care 1992; 15: 1477-1483.
30. Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V. Progressive deterioration of beta-cell function in nonobese diabetic subjects. Diabetes et Matabolisme 1996; 22: 185-191.
31. Skyler J, Marks J. Immune intervention in type 1 diabetes mellitus. Diabetes Rev 1993; 1: 15-42.
32. Schatz D. The diabetes prevention trial - Type 1 diabetes (DPT-1): design and implementation of the oral antigen (insulin) protocol. Diabetes 1995; 44: (suppl 1): 230A.